Vacancy: Postdoctoral Research Scientist – Epitranscriptomics
19 March 2024
Grade 7: Salary in range £36,024 - £44,263 per annum
Ludwig Oxford’s Helen Byrne recognised as an Honorary Doctor at Chalmers 2024
18 March 2024
Ludwig Oxford’s Helen Byrne has been recognised for her contributions and major efforts in the field of mathematical biology
International Women's Day within Ludwig Oxford
8 March 2024
Barnes Byrne De Val Lu Mehdipour Ratcliffe Tomkova Van den Eynde
The 8th March annually celebrates Women's achievements and we are delighted to celebrate the women researchers, students and staff within Ludwig Oxford
Factor-inhibiting HIF deficiency is found to create a tumour-promoting immune microenvironment
1 March 2024
A collaborative study by the Lu and Ratcliffe research groups has found that the tumour-promoting immune microenvironment can be created by a deficiency in factor-inhibiting HIF.
Vacancy: Scientific Data Manager
1 March 2024
Grade 8: £45,585 - £54,395 with a discretionary range to £59,421 per annum
Control of Wnt signalling by KDM5C during development impacts cognition
21 February 2024
Ludwig Oxford’s Yang Shi’s research team identifies KDM5C as a crucial sentinel for neurodevelopment.
Melanoma Genomic Instability increased by DNA damage remodelling the MITF interactome
6 February 2024
The Goding lab shows that Microphthalmia-associated Transcription Factor (MITF) plays a non-transcriptional role in shaping the DNA Damage Response programmes. MITF is phosphorylated on exposure to DNA damaging agents, and interacts with a DNA repair complex, increasing the level of genomic instability within cells which can have an impact on cancer initiation.
Ludwig Oxford celebrates the end of a successful year
13 December 2023
Ludwig Oxford meets as a whole to share their science and creativity in talks, posters, writing and art competitions and more for the end of year retreat
Insights made into how Red Hair Colour (RHC) trait variants may increase melanoma risk
30 November 2023
The Goding lab have worked in collaboration with Bill Pavan’s group of the National Human Genome Research Institute, at the National Institutes of Health (NIH), to uncover the transcriptomic profile of MC1R-inhibited melanocytes at single-cell resolution in Pigment Cell & Melanoma Research.
Ludwig Oxford DPhil candidate receives MSD Teaching Excellence Award
10 November 2023
Ludwig Oxford’s Olly Featherstone has been awarded an Early Career Excellent Teacher award by the Medical Sciences Division Teaching Excellence Awards.
New DPhil studentships in Cancer Science available for 2024 intake
30 October 2023
Boccellato Byrne Lu Rittscher Schuster-Böckler Tomkova Van den Eynde White
Ludwig Oxford supervised DPhil studentships in Cancer Science are now being advertised for the 2024 intake
Collaboration announced between Satisfai and University of Oxford to develop AI methods of evaluating Barrett's oesophagus
9 October 2023
An agreement between Satisfai Health Inc and the University of Oxford will forward the automated assessment of Barrett’s oesophagus, designed to determine patients with the highest risk of developing oesophageal cancer.
Acetylation reprograms MITF target selectivity and residence time
28 September 2023
Ludwig Oxford’s Colin Goding and his lab reveal an acetylation-mediated switch that suppresses differentiation and provides an explanation of why a human K206Q MITF mutation is associated with Waardenburg syndrome.
A role for ASPP2 in Hepatitis C infection
28 September 2023
Ludwig Oxford researchers in the Lu lab uncover new insights into the role of ASPP2 in Hepatitis C virus replication and transmission.
Ludwig Oxford Professor Announced
12 September 2023
Congratulations to Richard White who has been successful in the 2023 University recognition exercise.
Ludwig Oxford’s Dr Mehdipour in one of three University of Oxford teams shortlisted for Cancer Grand Challenges funding
5 September 2023
Dr Parinaz Mehdipour is a member in one of the 12 teams shortlisted for funding from Cancer Grand Challenges, seeking to understand retrotransposable elements in cancer.
Ludwig Oxford welcomes new Leadership Fellow Dr Marketa Tomkova
25 August 2023
Our new Leadership Fellow launches a research group in computational cancer genomics
Ludwig Oxford’s Richard White awarded for his Outstanding Research by the Society for Melanoma Research
18 August 2023
Richard White has been named for the 2023 Outstanding Research award by the Society for Melanoma Research
Comparative analysis of ADO and PHD enzymes allows researchers to better understand their co-evolution and integration into oxygen homeostasis mechanisms
17 August 2023
Ludwig Oxford’s Peter Ratcliffe and Tom Keeley have undertaken a comparative analysis of a number of enzymes involved in the adaption of cells to oxygen level changes.
Ludwig Oxford clinical trial shows Immunochemotherapy outcomes predicted by tumour monocyte content
11 July 2023
Lu Schuster-Böckler Van den Eynde
An analysis of samples obtained from a uniquely designed window-of-opportunity clinical trial (LUD2015-005) has shown that high tumour monocyte content (TMC) is an unexpected predictor of greater overall survival in inoperable oesophageal adenocarcinoma (OAC) patients.